BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29039480)

  • 1. MicroRNA-20b promotes cell proliferation via targeting of TGF-β receptor II and upregulates MYC expression in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2017 Dec; 51(6):1842-1850. PubMed ID: 29039480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.
    Qu Y; Zhang H; Duan J; Liu R; Deng T; Bai M; Huang D; Li H; Ning T; Zhang L; Wang X; Ge S; Zhou L; Zhong B; Ying G; Ba Y
    Oncotarget; 2016 May; 7(22):33286-96. PubMed ID: 27120811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
    Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
    PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.
    Mishra S; Deng JJ; Gowda PS; Rao MK; Lin CL; Chen CL; Huang T; Sun LZ
    Oncogene; 2014 Jul; 33(31):4097-106. PubMed ID: 24037531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.
    Li J; You T; Jing J
    Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.
    Yang S; Cho YJ; Jin L; Yuan G; Datta A; Buckhaults P; Datta PK
    Oncotarget; 2015 Oct; 6(32):33237-52. PubMed ID: 26356817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
    Xiang Y; Zhang Y; Tang Y; Li Q
    Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
    De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
    Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing's sarcoma cells.
    Tanaka K; Kawano M; Itonaga I; Iwasaki T; Miyazaki M; Ikeda S; Tsumura H
    Int J Oncol; 2016 Mar; 48(3):1135-44. PubMed ID: 26782922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
    Correia AC; Moonen JR; Brinker MG; Krenning G
    J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells.
    Koga C; Kobayashi S; Nagano H; Tomimaru Y; Hama N; Wada H; Kawamoto K; Eguchi H; Konno M; Ishii H; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S591-600. PubMed ID: 24740829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
    Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Kubota Y; Tsumura H
    Sci Rep; 2023 Oct; 13(1):18546. PubMed ID: 37899376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.